ARX vs MYX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

57MEDIUM

MYX

M PHARMA FPO [MYX]

51MEDIUM

Score Breakdown

ARX MYX
Technical
38
51
Catalyst
50
53
Sentiment
50
50
Fundamental
95
85
Momentum
55
38
Risk Gate
50
42

Key Metrics

ARX Metric MYX
$202.9MMarket Cap$233.2M
314KAvg Volume (20d)291K
N/AShort Interest+2.5%
$0.80052-Week High$6.500
$0.49552-Week Low$2.040
-0.8%Daily Change-0.7%
$0.580Reference Price$2.810
+4.9%ROE-20.6%
+4.5%Profit Margin-20.4%

Active Signals

ARX Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Above-average volume (1.6x) on a red day — sellers in control
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 3.3% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (2.0x)

MYX Signals

Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.6x)
EPS estimates revised upward (+10pts)
Near 52-week low (19% of range)
CANSLIM I: Institutional ownership (36%)
Deeply negative margins (-20%)

Ask Scout AI to compare ARX and MYX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ARX vs NAN →ARX vs NOX →ARX vs NYR →ARX vs PAR →ARX vs SPL →
ARX Full Analysis → MYX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).